There are so many different anti-depressants and the methods for choosing which ones are optimal basically come down to the intuition of the psychiatrist. It can take years to iterate through all the possible combinations of psychiatric medication if they keep failing to fix the neurotransmitter imbalance. I think anything short of 2 years is not long enough to conclude that a person’s brain is irreparably broken. It’s also a field that has a good chance of rapid development, such that a brain that seems irreparably broken today will certainly not always be unfixable.
--
I explored a business in psychiatric genetic testing, and identified about 20 different mutations that could help psychiatrists make treatment decisions, but it was infeasible to bring to market right now without having millions of dollars for research, and the business case is not strong enough for me to raise millions of dollars for research. It’ll hit the market within 10 years, sooner if the business case becomes stronger for me doing it or if I have the spare $20k to go out and get the relevant patent to see what doors that opens.
I expect the first consequence of widespread genetic testing for mental health is for NRIs to become much more widely prescribed as the firstline treatment for depression.
There are so many different anti-depressants and the methods for choosing which ones are optimal basically come down to the intuition of the psychiatrist. It can take years to iterate through all the possible combinations of psychiatric medication if they keep failing to fix the neurotransmitter imbalance. I think anything short of 2 years is not long enough to conclude that a person’s brain is irreparably broken. It’s also a field that has a good chance of rapid development, such that a brain that seems irreparably broken today will certainly not always be unfixable.
--
I explored a business in psychiatric genetic testing, and identified about 20 different mutations that could help psychiatrists make treatment decisions, but it was infeasible to bring to market right now without having millions of dollars for research, and the business case is not strong enough for me to raise millions of dollars for research. It’ll hit the market within 10 years, sooner if the business case becomes stronger for me doing it or if I have the spare $20k to go out and get the relevant patent to see what doors that opens.
I expect the first consequence of widespread genetic testing for mental health is for NRIs to become much more widely prescribed as the firstline treatment for depression.